Skip to main content
. 2019 Jan 17;17(3):2206–2220. doi: 10.3892/etm.2019.7183

Table IV.

Sequence statistics for each sample.

Case/time-point Total reads (n) Immune sequences (n) In-frame sequences (n) Out-of-frame sequences (n) Total CDR3 sequences (n) Unique CDR3 nt sequences (n) Unique CDR3 AA sequences (n)
Case 1
  Pre1 435,064 431,037 340,034 90,817 285,020 39,406 32,744
  Post1 496,537 486,442 268,278 217,707 182,009 18,828 15,331
  Post7 403,593 398,636 220,842 177,542 150,370 23,895 20,310
Case 2
  Pre1 572,795 480,031 404,703 75,068 352,553 51,913 43,978
  Post1 650,859 356,884 242,488 114,047 191,181 21,340 17,431
  Post7 588,477 323,629 253,726 69,720 209,382 29,920 25,090
Case 3
  Pre1 922,607 313,193 240,813 72,173 202,578 26,384 21,771
  Post1 130,4368 393,937 300,335 93,207 257,911 28,326 22,837
  Post7 770,650 383,720 271,055 112,466 224,214 24,027 19,428

Pre1, 1 day prior to transplantation; post7, 7 days post transplantation; CDR3, complementarity-determining region 3; nt, nucleotide; AA, amino acid.